Exact Sciences reports third-quarter revenue growth of 85 percent to $219 million
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Exact Sciences (EXAS) Tops Q3 EPS by 10c, FY Revenue Guidance Misses at Mid-Point
October 29, 2019 4:11 PM EDTExact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.31), $0.10 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $218.8 million versus the consensus estimate of $216.11 million.
GUIDANCE:
Exact Sciences sees FY2019 revenue of $802-810 million, versus the consensus of... More



